Completed clinical studies support the utility of ChemoFx® in identifying the relative responsiveness of tumor cells to various chemotherapy treatments that can be used by physicians to select appropriate treatments between clinically equivalent options.

For a list of publications, click here.

Contact Client Services for copies of any of the published papers or publications at 1.800.547.6165 or clientservices@ptilabs.com.